The Flaviviridae are a family of viruses that cause severe human diseases. For example, dengue virus (DENV) is a rapidly emerging pathogen causing an estimated 100 million symptomatic infections annually worldwide 1 . No approved antivirals are available to date, and clinical trials with a tetravalent dengue vaccine showed disappointingly low protection rates 2 . Hepatitis C virus (HCV) also remains a major medical problem, with 160 million chronically infected patients worldwide and only expensive treatments available 3 . Despite distinct differences in their pathogenesis and modes of transmission, the two viruses share common replication strategies 4 . A detailed understanding of the host functions that determine viral infection is lacking. Here we use a pooled CRISPR genetic screening strategy 5,6 to comprehensively dissect host factors required for these two highly important Flaviviridae members. For DENV, we identified endoplasmic-reticulum (ER)-associated multi-protein complexes involved in signal sequence recognition, N-linked glycosylation and ER-associated degradation. DENV replication was nearly completely abrogated in cells deficient in the oligosaccharyltransferase (OST) complex. Mechanistic studies pinpointed viral RNA replication and not entry or translation as the crucial step requiring the OST complex. Moreover, we show that viral non-structural proteins bind to the OST complex. The identified ER-associated protein complexes were also important for infection by other mosquito-borne flaviviruses including Zika virus, an emerging pathogen causing severe birth defects 7 . By contrast, the most significant genes identified in the HCV screen were distinct and included viral receptors, RNA-binding proteins and enzymes involved in metabolism.
mediated by several, but not all, signal sequences 10 (Fig. 1b, c, blue) . Genes involved in protein quality control and the ER-associated protein degradation (ERAD) pathway also scored highly (Fig. 1b, c, green) . Notably, in both the haploid and CRISPR genetic screens, the most significantly enriched genes were subunits of the OST complex, an enzyme essential for N-linked glycosylation (Fig. 1b, c, red) . This dependence on ER cellular genes is probably related to the expression of the DENV genome, which encodes an ER-targeted viral polyprotein containing signal sequences and viral glycoproteins. Given the similarities in DENV and HCV polyprotein expression, we expected these genes to also be represented in the HCV CRISPR screen. Surprisingly, there was no overlap between the DENV and HCV core sets of enriched genes, suggesting that these members of the Flaviviridae evolved divergent host factor dependencies ( Fig. 1c -e, Extended Data Fig. 1a, b , Supplementary Tables 3, 4 ). Indeed, cross-comparison of the most significant hits with both viruses suggested specific dependencies, although minor quantitative effects cannot be excluded (Extended Data Fig. 1c ). The robustness of the CRISPR approach was further underscored by the consistent identification of the core dependency factors in three independent replicate screens performed for each virus (Extended Data Fig. 2 ). We validated the novel DENV host factors in isogenic knockout cells using a plaque-forming assay and observed a marked reduction in particle formation (Extended Data Figs 3, 4a) . Importantly, complementation of knockout cells restored DENV infection (Extended Data Fig. 4b, c ). The relevance of the identified host factors was further confirmed in Raji DC-SIGN, a B-cell line commonly used to study DENV (Extended Data Fig. 4d ).
Struck by the distinct host factor requirements of DENV-2 and HCV, we sought to evaluate selected DENV-2-dependency factors against other mosquito-borne flaviviruses that are closely related to DENV ( Fig. 2a ). Using quantitative PCR (qPCR) in isogenic knockout cells, we found that West Nile virus (WNV), but not yellow fever virus (YFV) or Zika virus (ZIKV), was as sensitive as DENV-2 to the disruption of the tested ERAD genes, which is in line with previous reports implicating ERAD in WNV infection 11, 12 . A functional TRAP complex is important for DENV-2, YFV and ZIKV RNA replication, whereas WNV RNA abundance is only slightly reduced. Individual subunits of the OST complex displayed notably different phenotypes for the four related flaviviruses. Whereas knockout of STT3A and STT3B both completely abolished DENV-2 replication, only STT3A knockout affected YFV, WNV and ZIKV replication. When probing HCV replication in STT3A-and STT3B-knockout Huh7 cells using luciferase virus, we did not observe a substantial decrease (Extended Data Fig. 4e ).
Intrigued by the differential sensitivity to the catalytic OST subunits, we focused our mechanistic studies on the OST complex, which has not been linked to viral replication before. The highly conserved catalytic subunit of the OST complex, STT3, is duplicated into two paralogues STT3A and STT3B in mammalian cells, and each isoform is present LETTER RESEARCH in distinct protein complexes 13 (Extended Data Fig. 4f ). The STT3A complex is important for the co-translational N-linked glycosylation of most of the glycoproteins, whereas the STT3B complex is important for the co-translational or post-translational glycosylation of acceptor sites that have been skipped by the STT3A complex 14 . Despite their partially redundant functions in N-linked glycosylation, we found that all DENV serotypes required the presence of both catalytic subunits as well as MAGT1, the highest scoring gene in the CRISPR screen ( Fig. 2b) .
To pinpoint which step in the viral life cycle requires the OST complex, we first focused on viral entry. We did not observe major Significance of enrichment was calculated by RIGER analysis. The screens were performed in three replicates and the mean of the RIGER score is represented on the y axis. The 30 most enriched genes were coloured and grouped by function. e, Comparison of the 30 most enriched genes from the DENV and HCV CRISPR screens and their position based on the mean RIGER score. 
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differences in viral particle entry in OST-deficient cells ( Fig. 2c ). Next, we used a replicon assay that bypasses viral entry by electroporation of DENV RNA. Translation of the viral genome, apparent at time points up to 10 h, was equally efficient in OST-knockout cells as in wild-type cells (Fig. 2d ). In stark contrast, viral RNA replication (apparent at time points after 10 h) was completely abolished. This mirrored the expression pattern observed with a replication-deficient dengue mutant in the viral polymerase (NS5 GDD ). Thus, we show that the OST complex has a crucial involvement in viral RNA replication, after entry and translation of the viral genome.
Most glycoproteins can be efficiently modified by both OST isoforms and only a few are preferentially modified by either STT3A or STT3B 14 . Concordant with this, knockout of either STT3A or STT3B did not lead to loss of cellular viability, whereas a double knockout was lethal ( Fig. 3a ). We demonstrated that OST catalytic activity is required for cellular function using STT3A and STT3B mutants containing mutations in the residues that coordinate the binding of the divalent cation required for catalysis 15 (Fig. 3a , Extended Data Fig. 5 ). The functional redundancy between isoforms in global N-linked glycosylation is in contrast with the extreme dependence on each individual isoform of the OST complex for DENV replication. To investigate whether the effect of the OST complex is mediated by the necessity to glycosylate viral proteins properly, we focused on NS1, an enigmatic DENV glyco protein with essential roles in RNA replication 16 and pathogenesis 17 . NS1 was fully glycosylated in STT3A-and STT3Bknockout cells in contrast to the hypo-glycosylation of control cellular proteins known to be preferentially glycosylated by STT3A (pSAP) or STT3B (SHBG) (Fig. 3b ). This led us to speculate that the OST complex itself rather than its catalytic activity is required for DENV replication. To explore this hypothesis, we used the catalytic mutants of STT3A . Surprisingly, the catalytically dead mutants were able to restore fully DENV replication in STT3A-and in STT3B-knockout cells ( Fig. 3d ). We thus conclude that DENV RNA replication has hijacked a function of the human OST complex that is independent from its canonical role in N-linked glycosylation. The dispensability of the catalytic function of the OST complex further suggests a more structural role of OST in viral replication. The OST forms a stoichiometric complex at the ER membrane where DENV establishes a functional replication complex to initiate RNA replication. Our electron microscopy studies using APEX2 confirmed the localization of STT3B in the ER membrane, in close proximity to the membranous replication vesicles in DENV-2-infected cells (Extended Data Fig. 6a -c).
We next interrogated the physical interaction of the viral proteins with the OST complex by immunoprecipitation of STT3A-Flag and STT3B-Flag in the context of viral infection. Western blot analysis after immunoprecipitation showed that the non-structural proteins NS2B and NS3, components of the DENV replication complex, associate specifically with STT3A and STT3B ( Fig. 3e , Extended Data Fig. 6d ). Next, eluates of the immunoprecipitations (Extended Data Fig. 6e , f) were subjected to tryptic proteolysis and the resulting peptides were analysed by mass spectrometry. Identification of tryptic peptides from NS2A, NS3 and NS4A in the eluates pointed to their association with the OST complexes formed by STT3A and STT3B (Extended Data Fig. 6g , Supplementary Table 5 ). Taken together, this data suggests a structural role for the OST complex in DENV RNA replication through interactions with non-structural proteins that form the RNA replication complex. Our data indicate that the OST complex fulfils specialized roles in host pathogen interactions and is more multifaceted than previously recognized. In support of this emerging notion, two recent studies uncovered unexpected roles of the OST complex in immunity. The OST complex was found to be crucial for innate immune responses triggered by lipopolysaccharide 18 , and in a separate study OST dysregulation was identified as cause for autoimmune disorders triggered by certain TREX1 mutations 19 .
The HCV-resistant cell population was highly enriched in guide RNAs targeting the known HCV receptors 20 CD81, OCLN and CLDN1, confirming their non-redundant role in entry for HCV ( Fig. 1d , blue) and highlighting the validity of the screen results. The completeness of the screen was further underscored by the identification of microRNA-122 (ref. 21) and DGCR8 (Fig. 1d , green), which is part of the microRNA processing machinery, as key factors for HCV replication. Several dependency factors of HCV were validated in Huh7.5.1 cells, where knockout significantly reduced viral RNA and particle formation ( Fig. 4a , b, Extended Data Figs 7, 8a). After CLDN1, the second most significantly enriched gene was ELAVL1 (also known as HUR), an RNA-binding protein involved in mRNA stabilization 22 . In isogenic ELAVL1-knockout cells, HCV RNA replication was nearly abolished, while we did not observe a decrease with other RNA viruses (Extended Data Fig. 8b , c) including the alphavirus Sindbis, which contains strong ELAVL1-binding sites 23 . We used an HCV replicon assay to show that ELAVL1 has a critical role in HCV RNA replication, which is in line with a recent report 24 (Extended Data Fig. 8d, e ). Enzymatically active HCV-dependency factors (Fig. 1d , red) are by far the most important category of host factors for identifying antiviral drug targets. A case in point is cyclophilin A (PPIA) that has been actively pursued until phase III clinical trials 25 . We discovered enzymes with novel putative roles in HCV replication and explored these potentially 'druggable' factors further. We focused on RFK and FLAD1, enzymes involved in the two-step conversion of riboflavin (vitamin B2) to flavin adenine dinucleotide (FAD) ( Fig. 4c) . RFK-and FLAD1-knockout cells were resistant to HCV replication but not DENV (Extended Data Fig. 9a ). As predicted from their sequential role in FAD biogenesis, exogenous flavin mononucleotide (FMN) or FAD rescued HCV replication in 
RFK-knockout cells, whereas FAD but not FMN rescued viral replication in FLAD1-knockout cells ( Fig. 4d , Extended Data Fig. 9b ). This demonstrates that HCV replication is dependent solely on sufficient FAD levels. Modulation of intracellular FAD levels can be achieved by treatment of the cells with lumiflavin, a cellular uptake inhibitor of riboflavin 26 . Treatment of cells with lumiflavin greatly reduced HCV replication, while other RNA viruses were less sensitive to lumiflavin treatment ( Fig. 4e , Extended Data Fig. 9b-f ). We further pinpointed RNA replication as the step of the life cycle that requires FAD using a replicon system (Fig. 4f ). This highlights that knockout screens can identify specific host targets for antiviral drug discovery. Taken together, we used comparative genome-scale knockout screens to identify human genes with crucial roles in the replication of Flaviviridae.
Despite previous extensive interrogation of human host factors for these viruses through genomic and proteomic approaches 11, [27] [28] [29] [30] , we discovered marked dependencies on several host processes that had not been linked to flaviviral replication before ( Fig. 4g , Extended Data Fig. 10 ).
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METHODS
No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment. Haploid genetic screen. The haploid genetic screen was performed as previously described 9 . In short, 100 million gene-trap mutagenized HAP1 cells were seeded and infected with DENV-2 16681 (multiplicity of infection (MOI) = 5). Eight hours after infection, media was aspirated and replaced with IMDM containing 2% FBS. Clear cytopathic effects were observed after 3 days of infection leading to the death of most cells. Clusters of cells resistant to DENV-2 infection became apparent during further culture, and 9 days after infection cells were collected as a pool (yield ~ 30 million cells) and genomic DNA was isolated using a QIAamp DNA column. Gene-trap insertion sites were determined by linear amplification of the genomic DNA (gDNA) flanking regions of the gene-trap DNA insertion sites and sequenced on a Genome Analyzer II. Reads were aligned to the human genome using Bowtie and enrichment of independent insertions was calculated as previously described 9 . CRISPR genetic screens. Huh7.5.1 cells were stably transduced with lenti-Cas9-Blast and subsequently selected using blasticidin. Next, a total of 300 million Huh7.5.1 cells that constitutively express Cas9 were transduced with the len-tiGuide-Puro from the GeCKO v2 library 31 at a MOI of 0.3. Cells were selected with puromycin and pooled together. The CRISPR genetic screens were started 10 days after transduction. Approximately 60 million mutagenized cells for each library (A and B) were infected with DENV-2 16681 (replicate 1 and 2) or DENV-2 strain 429557 (replicate 3) using a MOI of 1, or with HCV JFH1 at a MOI of 0.3. Cytopathic effect was visible 2 and 5 days after infection for DENV and HCV, respectively. Huh7.5.1 cells grow slower than HAP1 cells and clusters of resistant cells took longer to develop. The selected cells were collected 16 days after infection.
As an uninfected reference we chose the unselected starting population because in these strong positive selection screens the selection pressure of the viral infections renders potential small growth differences of the mutagenized cells inconsequential. For both selected and uninfected control cells, gDNA was isolated using a QIAamp DNA column, and the inserted guide RNA sequences were amplified from the gDNA by flanking primers and prepared for next-generation sequencing. Resulting amplicons were sequenced on a MiSeq or NextSeq platform (Illumina) and the enrichment of each guide RNA was calculated by comparing the relative abundance in the selected and unselected population. RIGER analysis was performed on guide RNAs (with at least 10 reads) ranked by enrichment using the weighted sum statistical method 32 . Each CRISPR screen was performed in three replicates and the mean of the three RIGER scores was calculated. Cell culture. HAP1 cells were derived from the near-haploid chronic myeloid leukaemia cell line KBM7 as described earlier 9 . HAP1 cells and knockout derivatives were cultured in IMDM supplemented with 10% FBS, penicillin-streptomycin and l-glutamine. STT3A/STT3B double-knockout HAP1 cells were cultured in IMDM supplemented with 10% FBS, penicillin-streptomycin, l-glutamine and 25 ng ml −1 doxycycline. Huh7, Huh7.5.1 (both gifts from F. Chisari) and HEK293FT (Thermo Scientific) cells and knockout derivatives were grown in DMEM supplemented with 10% FBS, penicillin-streptomycin, non-essential amino acids and l-glutamine. HEK293FT cells were used to generate lentivirus vectors for cellular transductions. Raji DC-SIGN cells (a gift from E. Harris) were cultured in RPMI-1640 supplemented with 10% FBS, penicillin-streptomycin and l-glutamine. The cell lines have not been authenticated. Parental The following qPCR primers were used: DENV-2-forward: 5′-GCCCTTCT GTTCACACCAT-3′, reverse: 5′-GGCTCTGCCAATCAGTTCAT-3′; universal-DENV-forward: 5′-GGTTAGAGGAGACCCCTCCC-3′, reverse: 5′-GGTCTCCT CTAACCTCTAGTCC-3′; yellow fever forward: 5′-GAAATGCCTGCCC TTTATGA-3′, reverse: 5′-GCACATGGCAACAGAAGCTA-3′; Kunjin-forward: 5′-GCTTTGCCACCTCTCTTCAC-3′, reverse: 5′-CGGTTGATGGTTTCC ACTCT-3′; ZIKV-forward: 5′-ACCATACGGCCAACAAAGAG-3′, reverse: 5′-TCCACAGCCAGGAAGAGACT-3′; HCV-forward: 5′-TCTCTCAGTCC TTCCTCGGA-3′, reverse: 5′-AAGCCGGCTAGAGTCTTGTT-3′; SINV-forward: 5′-CGCGGTCACGTAAGGATAAT-3′, reverse: 5′-TTTGGCATTCTTCAGC ACAG-3′ ; polio-for ward: 5′ -CAACCTCCCACTGGTGACT T-3′ , reverse: 5′-ATTTCCCCTGCTCAACCTTT-3′; 18S-forward: 5′-AGAAAC GGCTACCACATCCA-3′, reverse: 5′-CACCAGACTTGCCCTCCA-3′; VEEV-forward: 5′-CAGGACGATCTCATTCTCAC-3′, reverse: 5′-TCATTCA CCTTGTACCGAACG-3′; HRV-14-forward: 5′-AAGCAATTTGGTGGTCC AAG-3′, reverse: 5′-ACACTGGGGTTTGAAGCACT-3′. Crystal violet staining. For virus infections, wild-type and knockout cell lines were plated out in either 24-or 96-well plates. Cells were infected with DENV-2 (16681), HCV, SINV or polio using a MOI of 1. Huh7-STT3A-KO-STT3B-KO-pLenti-TRE3G-CMV-STT3B cells were cultured in presence or absence of 25 ng ml −1 doxycycline. Cells were incubated for 48-120 h then fixed using 4% formaldehyde in PBS. Cell viability at time of fixation was determined by crystal violet staining. Plaque-forming units assay. Plaque assays were performed on BHK-21 cells. In brief, BHK-21 monolayers were grown to 80% confluency in 24-well plates and incubated for 1 h at 37 °C in 5% CO 2 with serially diluted virus supernatants from wild-type and mutant HAP1 cells infected with DENV, at a MOI of 0.1 for 48 h. The wells were then overlaid with DMEM, 0.8% Aquacide II (EMD Millipore), and 10% FBS, incubated for 7 days, and fixed with 10% formaldehyde. The cells were then stained overnight with crystal violet. The next day the wells were extensively washed with water then dried, and the resulting plaques were counted and plaque-forming units per ml were calculated. Two independent experiments were performed with triplicate infections and one representative is shown. Focus-forming units assay. Wild-type and knockout Huh7.5.1 cells were plated in 24-well plates and infected with HCV at a MOI of 0.1. Three days after infection, supernatant was collected and added to wild-type Huh7.5.1 cells in a tenfold dilution series. After 3 days, cells were fixed, stained with mouse-anti-HCV-core (Abcam ab2740) and anti-mouse-IgG-Alexa-488 (Life Technologies) and fluorescent colonies were counted. Two independent experiments were performed with triplicate infections and one representative experiment is shown. Luciferase reporter virus assays. Cells were plated out in 96-well plates in triplicates and infected with dengue luciferase reporter virus at an MOI of 0.01. Cells were incubated with dengue luciferase reporter virus at 37 °C, 5% CO 2 and cell lysates were collected. Luciferase expression was measured using Renilla Luciferase Assay system (Promega E2820). Cells were lysed using Renilla lysis buffer and luciferase activity measured by addition of substrate and immediate luciferase readings were taken using Glomax 20/20 luminometer using a 10-s integration time. For the cross-comparison of the effects of host factors on DENV and HCV Huh7.5.1 knockout cell lines were infected with dengue luciferase reporter virus at an MOI of 0.01 or with HCV luciferase virus at an MOI of 0.2. For the validation of HCV host factors, four different knockout cell lines (created using lentiCRISPRv2) were infected with HCV luciferase virus at an MOI of 0.2. Two independent experiments were performed with triplicate infections and one representative experiment is shown, with the exception of the experiment shown in Extended Data Fig. 4e , which was performed once with triplicate infections. Infection of Raji DC-SIGN cells. Raji DC-SIGN host factor knockout cell lines were created by transduction of lentiCRISPRv2 and subsequent puromycin selection. Resulting cell lines were infected with dengue luciferase virus at an MOI of 0.05 and collected 3 days after infection. Three independent experiments were performed with triplicate infections and one representative is shown. Internalization assay and confocal microscopy. Approximately 10,000 Huh7 cells were seeded on Laboratory-TekII Chamber slides (Thermo Fisher Scientific). The next day, cells were incubated on ice for 15 min, infected with DENV (MOI = 60) and incubated on ice for 1 h. Cells were washed three times with ice-cold PBS and subsequently incubated at 37 °C for 0 or 30 min. At each time point, 10 μ g ml −1 LETTER RESEARCH wheat germ agglutinin-Alexa-594 (Life Technologies, W11262) was added for 10 min at room temperature before three washes with PBS and fixation with 4% paraformaldehyde. Dengue virus was stained with a rabbit-anti-dengue-envelope antibody (Genetex, 127277) in block/perm buffer (1% saponin, 1% Triton X-100, 5% FBS) for 1 h followed by incubation with goat anti-rabbit-IgG-Alexa-488 (Life Technologies, A-11008) and DAPI (Insitus, F203) for 30 min. After three washes with PBS, cells were visualized using confocal microscopy. Replicon assays. Dengue replicon plasmid was linearized using XbaI restriction enzyme. Replicon RNA was generated using the MEGAscript T7 High Yield Transcription Kit (Ambion, AM1334) with the reaction containing 5mM m 7 G(5′)ppp(5′)G RNA Cap Structure Analogue (NEB, S1405S). Resulting RNA was purified by sodium acetate ethanol precipitation. HCV sgJFH1 replicon 33 RNA was prepared as described for DENV with the exception of adding the cap structure analogue. Cells were washed twice with PBS and re-suspended in electroporation buffer (Teknova, E0399). Three micrograms of purified replicon RNA was mixed with cells, and cells were electroporated using Bio-Rad Gene Pulser Xcell electroporator using square wave protocol. Electroporated cells were resuspended in cell culture medium without antibiotics and plated into 24-well plates. Luciferase expression was measured using Renilla Luciferase Assay system (Promega, E2820). Cells were lysed using Renilla lysis buffer and luciferase activity measured by addition of substrate and luciferase readings were taken immediately using Glomax 20/20 luminometer using a 10-s integration time. For lumiflavin treatment, cells were electroporated with 2 μ g of viral RNA and 1 μ g of firefly mRNA (Trilink) to normalize for effects on cell proliferation. For the lumiflavin treatment, two independent experiments with three electroporations each were performed. One representative experiment is shown. For the replicon assay in ELAVL1-knockout cells, three independent experiments with a single electroporation were performed. The average of the experiments is shown. For the DENV-replicon assay, three independent experiments were performed. One representative experiment was shown. Immunoblot analysis. Cell pellets were lysed using Laemmli SDS sample buffer containing 5% β -mercaptoethanol and boiled for 10 min. Lysates were separated by SDS-PAGE on pre-cast Bio-Rad 4-15% poly-acrylamide gels in Bio-Rad miniprotean gel system. Proteins were transferred onto PVDF membranes using Bio-Rad trans-blot protein transfer system. PVDF membranes were blocked with PBS buffer containing 0.1% Tween-20 and 5% non-fat milk. Blocked membranes were incubated with primary antibody diluted in blocking buffer and incubated overnight at 4 °C rotating. Primary antibodies were detected using horseradish peroxidase (HRP)-conjugated secondary anti-mouse and anti-rabbit antibodies (Genetex) by incubating membranes at a 1:5,000 dilution for 1 h at room temperature. Antibodybound proteins were detected by incubating with Pierce West Pico and Extended Duration Peroxide Solutions and visualized on film. Wild-type cells were treated with 10 μ g ml −1 tunicamycin and treated for 3-4 h at 37 °C, 5% CO 2 . To visualize proteins by immunoblotting, the following antibodies were used anti-SHBG (Genetex, GTX63795) at a dilution of 1:2,500. Anti-pSAP (Genetex, GTX101064) at a dilution of 1:2,500. Anti-HA C29F4 (Cell Signaling, 3724P) at a dilution of 1:2,500. Anti-mouse M2-Flag (Sigma, F1804-200UG) at a dilution of 1:2,500. Anti-DYKDDDDK (Flag) (Cell Signaling, 2368) at a dilution of 1:2,500. Anti-RPN1 (gift from M. Ivessa) at a dilution of 1:2,000. Anti-NS1 (Genetex GTX124280) at a dilution of 1:2,500. Anti-P84 (Genetex GTX70220) at a dilution of 1:3,500. Anti-DENV-ENV (Genetex GTX127277) at a dilution of 1:2,500. Anti-prM (Genetex, GTX128092) at a dilution of 1:2,500. Anti-NS2B (Genetex, GTX124246) at a dilution of 1:2,500. Anti-NS3 (Genetex, GTX124252) at a dilution of 1:2,500. Anti-RFK (Sigma, SAB1409492) at a 1:500 dilution. Anti-FLAD1 (Santa Cruz Bio, sc-376819) at a 1:250 dilution. Anti-STT3B (Sigma, HPA036646) at a dilution of 1:1,000. Anti-MAGT1 (Proteintech Group, 17430-1-AP) at a dilution of 1:1,000. Anti-RPS25 (Abcam, 102940) at a dilution of 1:1,000. Anti-HUR (Santa Cruz, sc-5261) at a dilution of 1:200. Anti-SRRD (Sigma, HPA002945) at a dilution of 1:500. Lentiviral or retroviral complementations. Lentiviral or retroviral transduction was used to create stable cell lines expressing a selected gene of interest. Respective genes of interest (see 'Construction of lenti-or retroviral constructs' section) were cloned into the pLenti-CMV-Puro-DEST vector (w118-1) (a gift from E. Campeau), or PMX-IRES-BLAST-DEST. Lentivirus or retrovirus produced in HEK293FT cells was used to transduce respective cell lines overnight. Cells stably expressing the gene of interest were selected by treatment with 1-4 μ g ml −1 puromycin or 10-50 μ g ml −1 blasticidin over 2 days (InvivoGen) along with untransduced cells as negative control. Genome engineering. CRISPR guide RNA sequences were designed using the Zhang laboratory CRISPR design tool (see Extended Data Fig. 3 for CRISPR target sites). Corresponding oligonucleotides or geneblocks containing U6 promoter sequence and U6 termination sequence were ordered from IDT. Oligonucleotides were cloned into the Zhang laboratory generated Cas9 expressing pX458 guide RNA plasmid (Addgene) as previously described using Gibson assembly reaction New England Biolabs. Geneblocks were cloned into pCR-Blunt II-TOPO vector (Life Technologies). TOPO-cloned geneblocks were co-transfected into respective cells with a mCherry-expressing construct and hCas9-expressing vector (Addgene 41815 hCas9 Church pcDNA3.3-Topo) guide RNA encoded in the pX458 plasmids were transfected alone using Lipofectamine 2000 (Life technologies) according to manufactures guidelines. Transfected cells were single-cell sorted based on GFP or mCherry expression into 96-well plates using BD influx cell sorter. Clonal cell lines were allowed to expand and genomic DNA was isolated for sequenced based genotyping of targeted allele. For this, a 500-700-base pair (bp) region that encompassed the guide RNA-targeted site was amplified and the PCR product was Sanger sequenced. In haploid cells (HAP1), only one mutated allele was present in the sequenced PCR product and cellular subclones containing a frame shift mutations or large indels were selected. In aneuploid Huh7.5.1 cells, we regularly observed that the PCR product contained more than 1 trace, suggesting non-identical mutations in multiple alleles. In this case, the PCR product was cloned into a plasmid vector and colonies were sequenced to separate allele specific mutations. Subclones were chosen where all alleles were mutated. It should be noted that in aneuploid Huh7.5.1 cells, we sometimes observed cellular subclones where all mutant alleles contained the same mutation (for example, CD81 and ELAVL1). It has been reported that CRISPR/Cas9 technology can generate homozygous bi-allelic mutations more frequently than expected in diploid cells or cancer cells 34, 35 , perhaps because both alleles were independently repaired in an identical manner or because one allele served as a template for homologydirected repair of the other allele. To create KO cell lines using lentiCRISPRv2 (Addgene) the following guide RNAs below were cloned into the vector, Huh7.5.1 cells were lentivirally transduced and selected with Puromycin. The following guide RNA sequences were used: ANKRD49: AGAAAGGAGTCTCCGCACTG; ANKRD49 guide2: ATGAACCGTTACGTCAAACC; ANKRD49 guide3: GCCCAAAGAAGCAATCTGCT; ANKRD49 guide4: AGAAAGGAGTCT CCGCACTG; CD81: GCGCCCAACACCTTCTATGT; CLDN1: CGATGGCG CCGATCCATCCC; ELAVL1: TTGGGCGGATCATCAACTCG; ELAVL1 guide2: TGTGAACTACGTGACCGCGA; ELAVL1 guide3: GGGCCT CCGAACCGTCGCGC; ELAVL1 guide4: AGAGCGATCAACACGCTGAA; EMC1: AGGCCGAATCATGCGTTCCT; EMC2: GATTGCCATTCGAAAA GCCC; EMC3: GTGCCACCTTCTCCTATGAC; EMC4: TGCTTGTCCAA GTAACCGAC; FKBPL: GTCAAGAAGATCGTAATCCG; FKBPL guide2: GAAGAGCCCGTCCATAGCAT; FKBPL guide3: ACAGAGCTAACT ATGGGCGT; FKBPL guide4: GTTTCGGTAGGAGGGTCTCG; FLAD1: ACAGACCATTGAGACCTCCC; FLAD1 guide2: CATGCGCATCAACC CACTGC; FLAD1 guide3: TACAGGAGTAGGGGTCAGTC; FLAD1 guide4: TGTGTCCCTGGGGGTTGAAG; MAGT1: GAGCGAACATGGCAGCGCGT; MIR-122: GAGTTTCCTTAGCAGAGCTG; MMGT1: CAGGCACTTACGCTG CGCAG; non-targeting: GCCCAGACGCCCTAGAATAG; OCLN: ACGTAGAGTCCAGTAGCTGC; OSTC: TCAGTCATAGAACCGACACT; PPIA: GTACCCTTACCACTCAGTCT; RFK: TATCATGCATACCTTCAAAG; RFK guide2: GGTCAAGTGGTGCGGGGCTT; RFK guide3: CTATGGGG AAATCCTCAATG; RFK guide4: CCAACCATAGTAAATACCAG; RPN2: TCGCTACCACGTGCCAGTTG; SRRD: GACTGTTCTCAGTGAGAACG; SRRD guide2: GATAGATACCTTTGCAATGT; SRRD guide3: ATTGAAGTCC TTAACACCCT; SRRD guide4: AACAACTGAAGGCCCCTGTG; SSR2: CAATAGCAGGGGGATGCCGA; SSR3: GACCCTAGTAAGCACATATT; STT3A: GTACTCACGGATCAAACTCA; STT3B: TACAGCAAAAGAGTCTACAT; ZEB1: TGAAGACAAACTGCATATTG.
TALENs targeting AUP1 in HAP1 cells were generated as indicated in Extended Data Fig. 3 . Cells were co-transfected with left and right TALEN-containing constructs and an mCherry-expressing construct using Lipofectamine 2000 (Life Technologies) according to manufacturer's guidelines. Transfected cells were single-cell sorted based on mCherry expression into 96-well plates using BD influx cell sorter. Subclones were allowed to expand and genomic DNA was isolated for sequenced based genotyping of AUP1 allele. HAP1 cells containing gene-trap insertions in STT3A, STT3B, RPN1, SSR2, SSR3, ASCC2 and RPS25 were isolated by picking resistant colonies from the DENV-2 haploid genetic screen. Picked colonies were screened for gene-trap insertions using PCR with primers directed to the gene-trap and the flanking region of the gene of interest. Co-immunoprecipitation. Wild-type HAP1 cells were transduced with STT3A-Flag, STT3B-Flag or RPS25-Flag lentiviral vectors (see 'Construction of lenti-or retroviral constructs' section). HAP1 cells expressing Flag-tagged proteins were trypsinized and washed once with PBS. Cells were lysed with TNM buffer (25 mM Tris-HCl, 15 mM NaCl, 5 mM MgCl 2 ) containing 1% digitonin, 1 mM PMSF, and Halt Protease and Phosphatase Inhibitor Cocktail (Life Technologies, 78440) for 1 h on ice gently vortexing every 15 min. Cell lysates were clarified by centrifugation at 15,000g for 10 min. Clarified lysates were incubated at 4 °C overnight
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with Anti-FlagG M2 Magnetic Beads (Sigma M8823-5ml). Incubated beads were washed three times with TNM buffer containing 0.1% digitonin, 1 mM PMSF, 1× halt protease and phosphatase inhibitor. Cells were washed once with TNM buffer and competitively eluted with TNM buffer containing 150 ng μ l −1 3× Flag Peptide (Sigma, F4799) for 30 min on ice. For immunoblotting, elutions were denatured by boiling in 5× sample buffer and analysed by SDS-PAGE using antibodies against DENV non-structural proteins. Elutions were also prepared for mass spectrometry analysis. Cells expressing RPS25-Flag, a host protein with a likely different mechanistic action, as well as untransduced cells, were used as a negative control in these experiments. SYPRO ruby staining. After electrophoresis gel was fixed for 30 min in fixative buffer (50% methanol, 7% acetic acid) and incubated with SYPRO Ruby Stain (Fischer, S-12000) overnight. Gels were then washed once with wash buffer (10% methanol, 7% acetic acid) and twice with distilled water. Gel was imaged on Molecular Dynamics Storm scanner. Construction of STT3A/STT3B double-knockout cell line with STT3B conditionally expressed using a Tet-On system. HAP1 cells stably transduced with the transactivator pLenti-CMVrtTA3G-Blast (R980-M38-658) (Addgene, 31797) with the endogenous STT3B gene disrupted by CRISPR/Cas9 were lentivirally transduced with pLenti-CMVTRE3G-Puro-STT3B-Flag, which drives STT3B under a doxycycline-inducible promoter. Transduced cells were then transfected with pX458 plasmid encoding a guide RNA targeted to the STT3A gene. Transfected cells were then subcloned based on GFP expression of PX458 plasmid into 96-well plates containing IMDM plus 10% FBS, penicillin-streptomycin, l-glutamine and 25 ng ml −1 doxycycline. Subclones were allowed to grow for 2 weeks, then replica plated and in one replicate the doxycycline medium was washed away and replaced with regular growth medium without doxycycline and incubated for 5 days. Cells that were dependent on doxycycline for growth were genotyped to verify both endogenous STT3A and STT3B had double frame shifting CRISPR/Cas9 editing events. STT3A/STT3B endogenous double knock out cells were then lentivirally transduced with wild-type or mutant STT3A or STT3B under the CMV promoter. The lentivirally transduced cell lines were then plated in 96-well plates and the doxycycline was washed away and incubated for 5 days. Cells were then fixed and stained with crystal violet to assess cell viability.
Treatment of HCV infected cells with lumiflavin, FMN and FAD.
Wild-type Huh7.5.1 cells were treated with lumiflavin (Santa Cruz Bio, sc-224045) ranging from 10 to 100 μ M and infected with HCV or DENV-2 at a MOI of 0.1. For WNV, YFV, PV (polio virus), SINV, VEEV and HRV-14 cells were treated with 50 μ M lumiflavin and infected at a MOI of 0.1. For rescue of HCV replication in lumiflavin-treated cells 100 μ M FMN and 10 mM FAD were used. RFK-and FLAD1-KO Huh7.5.1 were cultured in absence or presence of 500 μ M FMN (TCI America, R0023) or FAD (Sigma, F8384) and subsequently infected with HCV at a MOI of 0.1. After 3 days of infection, levels of infection were determined using immunofluorescence, western blot and qPCR. Anti-HCV core 1b (Abcam ab2740) was used at 1:500 for immunofluorescence and 1:1,000 for western blotting. Anti-DENV-2 NS5 (GeneTex GTX103350) was used at a 1:25,00 dilution for western blotting. For the lumiflavin treatment two independent experiments with triplicate infections were performed and one representative is shown. For the FMN/FAD complementation two independent experiments were performed and the average is shown. MTT assay. To test effects of lumiflavin on cell viability MTT assay was performed according to the manufacturer's instructions (Sigma Cell Proliferation Kit I (MTT), 11465007001). Three independent experiments in triplicates each were performed and one representative is shown. Transmission electron microscopy. Cells stably expressing STT3B-APEX2 were plated in 6-well plates and infected with an MOI 5 of DENV-2. 28 h after infection, cells were washed with PBS and fixed with 2% glutaraldehyde in 100 mM sodium cacodylate, 2 mM CaCl 2 , pH 7.4, buffer. Cells were fixed at 4 °C for 60 min then washed three times with PBS. Fixed cells were quenched with 100 mM sodium cacodylate, 2 mM CaCl 2 , pH 7.4, and 20 mM glycine. Quenched cells were washed twice with PBS and stained with using the KPL DAB reagent set (KPL, 54-10-00) for 8 h. After incubation with DAB, cells were rinsed twice with PBS and scraped off well using a cell scraper and pelleted. Pelleted cells were re-suspended in 10% gelatin in 0.1 M sodium cacodylate buffer, pH 7.4, at 37 °C and allowed to equilibrate for 5 min. Cells were pelleted again, excess gelatin removed, then chilled in cold blocks and covered with cold 1% osmium tetroxide (EMS, 19100) for 2 h rotating in a cold room. They were then washed three times with cold ultrafiltered water, then en bloc stained overnight in 1% uranyl acetate at 4 °C while rotating. Samples were then dehydrated in a series of ethanol washes for 20 min each at 4 °C beginning at 30%, 50%, 70%, 95% where the samples were then allowed to rise to room temperature, changed to 100% ethanol twice, then propylene oxide for 15 min. Samples were then infiltrated with EMbed-812 resin (EMS, 14120) mixed 1:2, 1:1 and 2:1 with propylene oxide for 2 h each with leaving samples in 2:1 resin to propylene oxide overnight rotating at room temperature in the hood. The samples were then placed into EMbed-812 for 2-4 h then placed into molds with labels and fresh resin, orientated and placed into a 65 °C oven overnight. Sections were taken at approximately 80 nm, picked up on formvar/carbon-coated 100-mesh Cu grids, stained for 30 s in 3.5% uranyl acetate in 50% acetone followed by staining in 0.2% lead citrate for 3 min. Observed in the JEOL JEM-1400 120kV and photos were taken using a Gatan Orius 4k × 4k digital camera.
Mass spectrometry
Liquid chromatography-tandem mass spectrometry. Elutions from coimmunoprecipitations were trypsin digested and purified using Sep Pak C18 purification column. Peptides were analysed using an LTQ Velos Orbitrap mass spectrometer (Thermo Fisher Scientific) coupled to an Agilent 1100 high performance liquid chromatography pump (Agilent Technologies) and a MicroAS autosampler (Thermo Fisher Scientific). Peptide mixtures were introduced into the mass spectrometer via a fused silica microcapillary column (100 μ m inner diameter) ending in an in-house pulled needle tip (internal diameter ≈ 5 μ m). Columns were packed to a length of 17 cm with a C18 reversed-phase resin (Magic C18AQ; Michrom Bioresources). Peptides were loaded onto the column and then eluted into the nanospray ionization source of the mass spectrometer via a two-step gradient of 7-25% buffer B (2.5% water and 0.1% formic acid in acetonitrile (v/v)) in buffer A (2.5% acetonitrile and 0.1% formic acid in water (v/v)) over 60 min followed by a second phase of 25-45% buffer B over 20 min. Eluting peptides were measured by the LTQ Velos Orbitrap operating in a data-dependent mode in which 10 ion-trap MS/MS spectra were acquired per data-dependent cycle from a high-resolution (R = 60,000) precursor spectrum (mass range = 360-1,600 m/z). Mass spectrometry data processing. Raw data files produced by the mass spectrometer were converted to the mzXML format using in house software, MS Convert. MS and MS/MS data were extracted from mzXML files with in-house software. MS/MS spectra were analysed using Sequest algorithm searching a composite target-decoy protein sequence database. The target sequences consisted of human proteins downloaded from the Uniprot database (11-17-2014) and protein sequence corresponding to the dengue virus 2 16681 polyprotein. Decoy sequences were created by reversing the orientation of all target sequences. Parameters used for all searches included the requirement of trypsin peptide cleavage, two missed cleavages allowed, peptide mass tolerance of 20 p.p.m., variable oxidation of methionine residues (+ 15.99491 Da), and static carbamylation modification of cysteine residues (+ 57.02146). Decoy peptide identifications guided the creation of filtering criteria delivering preliminary sets of peptide-spectrum matches with estimated false discovery rate < 1%. Spectral counts for each condition were combined at a protein level and normalized by protein length to infer protein abundances in each case.
DENV reporter virus and DENV replicon design and generation
Construction of pDENV-Luc replicon. The design of the DENV replicon was based on DVRep described previously 36 : The viral 5′ untranslated region (UTR) was followed by a duplication of the first 102 nucleotides of the C coding region, which contain cis-acting elements required for replication (CAE). The CAE was fused to the renilla luciferase coding region followed by the DENV open reading frame (ORF) starting at the signal peptide preceding NS1. Between the luciferase and the DENV structural proteins a foot and mouth disease virus (FMVD) 2A sequence was introduced to provide cotranslational cleavage and release of luciferase. The construct was based on pD2/IC-30P, which contains a full-length infectious clone encoding DENV-2 strain 16681 (ref. 37) . We also included the amino acid mutation Q399H in the envelope protein. We gene-synthesized a fragment containing the T7 polymerase promoter sequence followed by the first 102 nucleotides of the C coding region in frame with Renilla luciferase and FMDV 2A followed by the DENV open reading frame (ORF) starting at the signal peptide preceding NS1 until an internal HpaI site. This fragment was released by SacI (preceding the T7 promoter) and HpaI and cloned in pD2/IC-30P in a three point ligation with KpnI/SacI and KpnI/HpaI fragments. Construction of pDENV-Luc infectious clone. The design of the DENV reporter was based on mDV-R described previously 38 : The viral 5′ UTR was followed by a duplication of the first 104 nucleotides of the C coding region, which contain cis-acting elements required for replication (CAE). The CAE was fused to the renilla luciferase coding region followed by the complete DENV ORF. Between the luciferase and the DENV structural proteins a FMVD 2A sequence was introduced to provide cotranslational cleavage and release of luciferase. The construct was based on pD2/IC-30P, which contains a full-length infectious clone encoding dengue virus serotype 2 strain 16681 (ref. 37) in which an envelope Q399H mutation was introduced that enhanced viral infection in mammalian cells using primers 5′-GGAAGTTCTATCGGCCACATGTTTGAGACAAC-3′ and 5′-GTTGTCTCAAACATGTGGCCGATAGAACTTCC-3′ via the QuikChange Site-Directed Mutagenesis kit (Agilent Technologies). We gene-synthesized a fragment containing the T7 polymerase promoter sequence LETTER RESEARCH followed by the first 104 nucleotides of the C coding region in frame with Renilla luciferase and FMDV 2A. This fragment was PCR amplified, introducing a SacI site at the 5′ end and a NheI site (present in the FMDV 2A sequence) at the 3′ end using primers: 5′-CGAAATTCGAGCTCACGCG-3′ and 5′-TCCTGCTAGCTTGAGCAAATCAAAGTTC-3′. To create an in-frame fusion of FMDV 2A with the DENV ORF a second DNA fragment was amplified using pD2/IC-30P as template with primers: 5′-T CA AG CT AG CA GG AG AC GT TG AG TC CA AC CC CG GG CC CA TG AA TAACCAACGGAAAAAGGCG-3′ and 5′-GGAAGAGCATGCAGTCGGAAATG-3′ introducing 5′ NheI and 3′ SphI restriction sites. The two fragments were cut with the respective restriction enzymes and ligated into pD2/IC-30P cut with SacI and SphI to create pDENV-Luc. DENV-Luc virus was produced by cutting with XbaI to linearize plasmid and in vitro transcription performed of pDENV-Luc and transfection into BHK cells using Lipofectamine 2000. Construction of lenti-or retroviral constructs. PMX-IRES-BLAST-DEST was made by cutting pMXs-IRES-Blasticidin Retroviral Vector (Cell Biolabs, RTV-016) with SnaBI and the Gateway destination cassette (reading frame A) was blunt cloned in to this vector according to manufacturer's protocol (Gateway Vector Conversion System; Invitrogen, 11828-029)
To generate a lentiviral construct expressing STT3A-Flag, Dharmacon cDNA BC020965 was used as template to generate a PCR product using primers 5′-CACCATGACTAAGTTTGGATTTTTGCG-3′ and 5′-TTACTT ATCGTCGTCATCCTTGTAATCTGTCCTTGACAAGCCTCGATT-3′
Amplified PCR product was then topo cloned into Gateway compatible entry vector pENTR/D-TOPO Cloning Kit (Life Technologies K2400-20) and gateway reaction (Life Technologies) used to insert into pLenti-CMV-Puro-Dest (w118-1).
To generate a lentiviral construct expressing STT3B-Flag, Dharmacon cDNA BC052433 was used as template to generate PCR product using primers forward p r i mer 5 ′-C A C C A TG T C T T G G TG G G AT TATGGC-3′ a n d r e v e r se p r i mer 5 ′-TTA CTTATCGTCGTCATCCTTGTAATCAACAGTCTTCTTAGAGGTCTTCTT-3′. It should be noted that we used Mus musculus STT3B because we were unable to clone human STT3B.
Amplified PCR product was then TOPO cloned into Gateway compatible entry vector pENTR/D-TOPO Cloning Kit (Life Technologies, K2400-20) and gateway reaction was used to insert into pLenti-CMV-Puro-Dest (w118-1).
To generate an SHBG-expressing construct, SHBG was ordered as two geneblocks and used to generate PCR product with primers 5′-TGTG GTGGAATTCTGCAGATACCTGTGGTGGAATTCTGCAGATACC-3′ and 5′-ATCCAGCACAGTGGCGG-3′. PCR product was Gibson cloned Gibson assembly reaction kit (New England Biolabs) into pLenti-CMV-Puro-Dest (w118-1) that was EcoRV digested.
To generate a Flag3× -RPS25 expression construct, entry vector PENTR-Flag3× -RPS25 was generated as described 39 using the forward primer CACCATGGACTACAAAGACCATGACGG. PENTR-Flag3× -RPS25 was then used in a Gateway reaction (Life Technologies) to introduce Flag3× -RPS25 into PMX-IRES-BLAST-DEST retroviral expression construct.
A construct expressing STT3B fused with APEX2 and Flag-tagged PCR products were generated using the pLenti-STT3B expression construct described above and APEX2 Addgene plasmid 49386 (refs 40, 41) as templates to generate PCR products using primers 5′-GACTCTAGTCCAGTGTGGTG-3′ with 5′-AACAGTCTTCTTAGAGGTCTTC-3′ and 5′-GAAGACCTCTAAG AAGACTGTTATGGACTACAAGGATGACGA-3′ with 5′-CGGCCGCCACT GTGCTGGATTTAGGCATCAGCAAACCCAAG-3′. PCR products were Gibson assembled Gibson assembly reaction kit (New England Biolabs) into pLenti-CMV-Puro-Dest (w118-1) that was EcoRV digested.
To generate a STT3B-doxycycline-lenti construct, Dharmacon cDNA BC052433 was used as a template to generate PCR product using primers 5′-CACCATGTCTTGGTGGGATTATGGC-3′ and 5′-T TA CT TA TC GT CG TC A T CC TT GT AA TC AA CA GT CT TCTTAGAGGTCTTCTT-3′
Amplified PCR product was then TOPO cloned into Gateway compatible entry vector pENTR/D-TOPO Cloning Kit (Life Technologies, K2400-20), and gateway reaction was used to insert into the doxycycline inducible lentiviral vector pLenti CMVTRE3G Puro DEST (w811-1) (Addgene, 27565).
To generate catalytic site mutants (Extended Data Fig. 5 and refs 15, 42) , STT3A-and STT3B-expressing constructs, DNA fragments were generated using pLenti-STT3B-Flag described above as a template using pLenti-EcoRV primers and mutant primers to generate two PCR products (see primers below). Both PCR products for each mutation were Gibson cloned (Gibson assembly reaction kit; New England Biolabs) into pLenti-CMV-Puro-Dest (w118-1) that was EcoRV digested.
Primers forward (F) and reverse (R) were as follows: pLenti EcoRV-F 5′-GACTCTAGTCCAGTGTGGTG-3′, pLenti EcoRV-R 5′-ATCCAGAGGTTGAT TGTCGAG-3′. STT3A mutations: E63A-F 5′-CAGGTTCCTGGCTGAGGC CGGGTTTTATAAATTCCATAACTGG-3′, E63A-R 5′-CCGGCCTCAGCC AGGAACCTG-3′; D167A-F 5′-CTGTGGCTGGCTCCTATGCCAATGA AGGGATTGCCATCTTTTG-3′, D167A-R 5′-CATTGGCATAGGAGCCAGCC ACAG-3′; E351Q-F 5′-CCATCATTGCTTCTGTGTCTCAGCATCAGCCC ACAACCTG-3′, E351Q-R 5′-ATGCTGAGACACAGAAGCAATGATGG-3′. STT3B mutations: D100A-F 5′-ATCATCCACGAGTTCGCCCCGTGGTTTAAC TATAG-3′, D100A-R 5′-CTATAGTTAAACCACGGGGCGAACTCGTG GATGAT-3′; D218A-F 5′-CAGTGGCGGGATCCTTTGCCAATGAAGGCATTG CCATT-3′, D218A-R 5′-AATGGCAATGCCTTCATTGGCAAAGGATCCCG CCACTG-3′; E402Q-F 5′-CAATTATTGCATCAGTGTCTCAGCATCAGCCTA CGACATGG-3′, E402Q-R 5′-CCATGTCGTAGGCTGATGCTGAGACAC TGATGCAATAATTG-3′.
ELAVL1 fused with Flag cDNA was prepared from total RNA of Huh7.5.1 cells using Biorad RT Superscript, and ELAVL1 was PCR amplified with 5′-TGTGGTGGAATTCTGCAGATACCATGTCTAATGGTTATGAAGACCA-3′ and 5′-C GG CCGCCACTGTGCTGGATTTACTTATCGTCGTCATCCTTGT AATCTTTGTGGGACTTG-3′. Next, using Gibson Assembly the PCR product was cloned into pLenti-CMV-Puro-Dest (w118-1) that was digested with EcoRV.
To generate RPN1 fused to 2Strep cDNA, BC010839 was PCR amplified with 5′-CACCATGGAGGCGCCAGCCGC-3′ and 5′-CTACAGGGCATCCAG GATG-3′. The amplified fragments were cloned into P-ENTR-D-Topo (Invitrogen) then a Gateway LR reaction was performed to shuttle cDNA into pLenti-CMVpuro expression vector.
To generate SSR2 fused to 2Strep cDNA, NM_003145.3 was PCR amplified with 5′-CACCATGAGGCTGCTGTCATTTGTG-3′ and 5′-TCAGTTCTTC TTCGTTTTGGGAG-3′. The amplified fragments were cloned into P-ENTR-D-Topo (Invitrogen) then a Gateway LR reaction was performed to shuttle cDNA into pLenti-CMV-puro expression vector.
To generate SSR3 fused to 2Strep cDNA, NM_003145.3 was PCR amplified with 5′-CACCATGGCTCCTAAAGGCAGCTC-3′ and 5′-CTATTTGGA GCCAGTAGACAG-3′. The amplified fragments were cloned into P-ENTR-D-Topo (Invitrogen) then a Gateway LR reaction was performed to shuttle cDNA into pLenti-CMV-puro expression vector.
To generate ASCC2 fused to 2Strep, BC025368 was PCR amplified with 5′-CACCATGCCAGCTCTGCCCCTGG-3′ and 5′-TCAGGATGGG ATCATGCCTTTGCT-3′. The amplified fragments were cloned into P-ENTR-D-Topo (Invitrogen) then a Gateway LR reaction was performed to shuttle cDNA into pLenti-CMV-puro expression vector.
To generate RPS25 fused to 2Strep, NM_001028 was PCR amplified with 5′-CACCATGGACTACAAAGACCATGACG-3′ and 5′-TTAATTA ACCTCGAGTTTAAACGCG-3′. The amplified fragments were cloned into P-ENTR-D-Topo (Invitrogen) then a Gateway LR reaction was performed to shuttle cDNA into pLenti-CMV-puro expression vector.
To generate the UBE2J1 expression construct, cDNA provided by R. Kopito was PCR amplified with 5′-TGTGGTGGAATTCTGCAGATACCATG GAGACCCGCTACAACCTG-3′ and 5′-CGGCCGCCACTGTGCTGGATTT ATAACTCAAAGTCAAATATGTATTC-3′. The amplified fragments were cloned into pLenti-CMV-puro expression vector by a Gibson Assembly reaction.
To generate the SEL1L expression construct, cDNA provided by R. Kopito was PCR amplified with 5′-TGTGGTGGAATTCTGCAGATACCATGCGGG TCCGGATAGGGCTG-3′ and 5′-CGGCCGCCACTGTGCTGGATTTAAA GTCTACTTACCAAAACCATG-3′. The amplified fragments were cloned into pLenti-CMV-puro expression vector by a Gibson Assembly reaction.
To generate AUP1, glycerol stocks containing AUP1 cDNA in pENTR entry vector were ordered from Darmacon (OHS5894-99868092), and a Gateway LR reaction was performed to shuttle cDNA into pLenti-CMV-puro expression vector. Comparison of knockout screens to siRNA screens. To compare the top 30 host factor genes of the knockout screens to results from previous short interfering RNA (siRNA) screens, we used the following data: (1) Sessions et al. 27 (supplementary table 2 ). To rank the list by strength of phenotype, we used the P value. If multiple siRNA sequences per gene were present, we used the one with the stronger effect. (2) Krishnan et al. 11 (supplementary table 1). To rank the identified DENV host factor, column AM was filtered for 'required by both WNV and dengue' . The remaining genes were sorted by 'pooled siRNA Fold reduction of DENV' (column AN). (3) Tai et al. 29 (table S2) . To sort by phenotype, we chose the validated genes scoring with at least two siRNAs and ranked by P value. (4) Li et al. 28 (from dataset S1). To rank the genes, we took the mean of the average normalized percentage infected cells part one or two of the four siRNAs. The top 10 genes based on phenotype as explained above are shown in Extended Data Fig. 10 . Arrow indicates site of 260-bp insertion. c, CRISPR Cas9 nuclease was targeted to bases depicted in red in HAP1 cells. Editing events are depicted at the guide RNA target sites below the wild-type sequence. d, CRISPR Cas9 nuclease was targeted to bases depicted in red in Huh7 cells. Editing events are depicted at the guide RNA target sites below the wild-type sequence. e, Immunoblots of wild-type and knockout cell lines.
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